S
Siyuan Shen
Researcher at University of Massachusetts Medical School
Publications - 21
Citations - 889
Siyuan Shen is an academic researcher from University of Massachusetts Medical School. The author has contributed to research in topics: DNA vaccination & Medicine. The author has an hindex of 10, co-authored 12 publications receiving 850 citations.
Papers
More filters
Journal ArticleDOI
Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime–protein boost HIV-1 vaccine in healthy human volunteers
Shixia Wang,Jeffrey S. Kennedy,Kim West,David C. Montefiori,Scott Coley,John M. Lawrence,Siyuan Shen,Sharone Green,Alan L. Rothman,Francis A. Ennis,James Arthos,Ranajit Pal,Phillip D. Markham,Shan Lu +13 more
TL;DR: It is demonstrated that the DNA prime-protein boost approach is an effective immunization method to elicit both humoral and cell-mediated immune responses in humans, and that a polyvalent Env formulation could generate broad immune responses against HIV-1 viruses with diverse genetic backgrounds.
Journal ArticleDOI
Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E
Shixia Wang,Ranajit Pal,John R. Mascola,Te-hui W. Chou,Innocent Mboudjeka,Siyuan Shen,Qin Liu,Stephen Whitney,Timothy Keen,B. C. Nair,Vaniambadi S. Kalyanaraman,Philip Markham,Shan Lu +12 more
TL;DR: It is suggested that DNA priming followed by recombinant Env protein boosting can be used to deliver polyvalent Env-antigen-based HIV-1 vaccines to elicit neutralizing antibody responses against viruses with diverse genetic sequence variations.
Journal ArticleDOI
Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine.
Shixia Wang,Diego J. Farfán-Arribas,Siyuan Shen,Te-hui W. Chou,Allison Hirsch,Feng He,Shan Lu +6 more
TL;DR: Optimized antigen expression, enhancement of viral promoter function and selection of secretary leader sequences were evaluated for their roles in improving the immunogenicity of a same model antigen, the HIV-1 envelope glycoprotein and demonstrated that all these factors can work synergistically to improve the final antigen expression and immunogensicity of HIV- 1 Env DNA vaccines.
Journal ArticleDOI
Enhanced Immunogenicity of gp120 Protein When Combined with Recombinant DNA Priming To Generate Antibodies That Neutralize the JR-FL Primary Isolate of Human Immunodeficiency Virus Type 1
Shixia Wang,James Arthos,John M. Lawrence,Donald Van Ryk,Innocent Mboudjeka,Siyuan Shen,Te-hui W. Chou,David C. Montefiori,Shan Lu +8 more
TL;DR: The results suggest that Env DNA priming followed by gp120 protein boosting provides an advantage over either approach alone for generating a detectable neutralizing antibody response against primary isolates that are not easily neutralized.
Journal ArticleDOI
Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype
Ranajit Pal,Shixia Wang,Vaniambadi S. Kalyanaraman,B. C. Nair,Stephen Whitney,Timothy Keen,Lindsey Hocker,Lauren Hudacik,Nicolas Rose,Innocent Mboudjeka,Siyuan Shen,Te-Hui Wu-Chou,David C. Montefiori,John R. Mascola,Phillip D. Markham,Shan Lu +15 more
TL;DR: Priming with DNA encoding Env antigens from multiple HIV-1 clades followed by boosting with homologous Env proteins elicits anti-HIV-1 immune responses capable of protecting macaques against mucosal transmission of R5 tropic SHIV isolate.